This report describes a case of a male infant diagnosed with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection who was prescribed favipiravir therapy. The mother noticed a discoloration of the child's eyes within 18 h of therapy, and the cornea returned to normal color within 5 days of medication cessation. This case report highlights the need for monitoring of favipiravir therapy in children due to the potential side effect of corneal discoloration, which has not yet had its long-term effects identified.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154467 | PMC |
| http://dx.doi.org/10.3389/fped.2023.1154814 | DOI Listing |
Publication Analysis
Top Keywords
case report
8
corneal discoloration
8
favipiravir therapy
8
report favipiravir-induced
4
favipiravir-induced bluish
4
bluish corneal
4
discoloration infant
4
infant covid-19
4
covid-19 report
4
report describes
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!